Institutional investors purchased a net $2.0 million shares of MNKD during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 25.75% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MIGDAL MUTUAL FUNDS LTD. Bought 1.1 Million shares of Mannkind Corp
BARCLAYS CAPITAL, INC. Bought 868.6 Thousand shares of Mannkind Corp
IBI MUTUAL FUNDS MANAGEMENT (197... Bought 813.7 Thousand shares of Mannkind Corp